Abstract
Despite a higher incidence of HPV-related cancer in HIV-positive (HIV+) patients (pts), pivotal studies with curative chemoradiation (CRT) in anal cancer do not include this population. The impact of HIV infection remains unknown in this scenario. This study aimed to compare overall survival (OS) according to HIV status.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Annals of oncology : official journal of the European Society for Medical Oncology
Paper Title
Journal
Date
